Role of corin in trophoblast invasion and uterine spiral artery remodelling in pregnancy

Nature

Volumn 484, Issue 7393, 2012, Pages 246-250

  Cui, Yujie ^a,d   Wang, Wei ^a,e   Dong, Ningzheng ^b   Lou, Jinglei ^a   Srinivasan, Dinesh Kumar ^a,f   Cheng, Weiwei ^c   Huang, Xiaoyi ^c   Liu, Meng ^b   Fang, Chaodong ^b   Peng, Jianhao ^a   Chen, Shenghan ^a   Wu, Shannon ^a   Liu, Zhenzhen ^b   Dong, Liang ^b   Zhou, Yiqing ^b   Wu, Qingyu ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b SOOCHOW UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d TIANJIN MEDICAL UNIVERSITY   (China)

^e PEKING UNION MEDICAL COLLEGE   (China)

^f LEE KONG CHIAN SCHOOL OF MEDICINE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CORIN; CYCLIC GMP; MESSENGER RNA; PROTEINASE; UNCLASSIFIED DRUG;

BIOCHEMISTRY; BLOOD; CARDIOVASCULAR SYSTEM; CYTOLOGY; DEVELOPMENTAL BIOLOGY; DISEASE INCIDENCE; ENZYME ACTIVITY; FUNCTIONAL ROLE; GENE EXPRESSION; HOMINID; HORMONE; MUTATION; PEPTIDE; PHYSIOLOGICAL RESPONSE; PREGNANCY; PROTEIN; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INVASION; CONTROLLED STUDY; DECIDUA; ENZYME ACTIVITY; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEINURIA; TROPHOBLAST; UTERINE ARTERY;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; CASE-CONTROL STUDIES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; ISCHEMIA; KIDNEY; KIDNEY DISEASES; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MUTATION; PRE-ECLAMPSIA; PREGNANCY; SERINE ENDOPEPTIDASES; TROPHOBLASTS; UTERINE ARTERY; UTERUS;

MUS;

EID: 84862778346     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature10897     Document Type: Article

References (33)

1. Pijnenborg, R., Vercruysse, L & Hanssens, M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 27, 939-958 (2006).
2. Red-Horse, K. et al. Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J. Clin. Invest 114, 744-754 (2004).
3. Wu, Q., Xu-Cai, Y. O., Chen, S. & Wang, W. Corin: new insights into the natriuretic peptide system. Kidney Int. 75, 142-146(2009).
4. Yan, W., Sheng, N., Seto, M., Morser, J. & Wu, Q. Corin, a mosaic transmembrane serine protease encoded bya novel cDNAfrom human heart. J. Biol. Chem. 274, 14926-14935 (1999).
5. Lain, K. Y. & Roberts, J. M. Contemporary concepts of the pathogenesis and management of preeclampsia. J. Am. Med. Assoc. 287, 3183-3186 (2002).
6. Sibai, B., Dekker, G. & Kupferminc, M. Pre-eclampsia. Lancet365, 785-799(2005).
7. Brosens, I. A., Robertson, W. B. & Dixon, H. G. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol. Annu. 1, 177-191 (1972).
8. Kaufmann, P., Black, S. & Huppertz, B. Endovascular trophoblast invasion: mplications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol. Reprod. 69, 1-7 (2003).
9. Norwitz, E. R., Schust, D. J. & Fisher, S. J. Implantation and the survival of early pregnancy. N. Engl. J. Med. 345, 1400-1408 (2001).
10. Kanasaki, K. et al. Deficiency in catechol-O-methyltransferaseand 2-methoxyoestradiol is associated with pre-eclampsia. Nature 453, 1117-1121 (2008).
11. Levine, R. J. et al. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 350, 672-683 (2004).
12. Redman, C. W. & Sargent, I. L Latest advances in understanding preeclampsia. Science 308, 1592-1594 (2005).
13. Venkatesha, S. et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nature Med. 12, 642-649 (2006).
14. Zhou, C. C et al. Angiotensin receptor agonistic autoantibodies induce pre¬eclampsia in pregnant mice. Nature Med. 14, 855-862 (2008).
15. Yan, W., Wu, F., Morser, J. & Wu, Q. Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme. Proc. Natl Acad. Sci. USA 97, 8525-8529 (2000).
16. Chan, J. C. et al. Hypertension in mice lacking the proatrial natriuretic peptide convertase corin. Proc. Natl Acad. Sci. USA 102, 785-790 (2005).
17. Dries, D. L et al. Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and hypertension Circulation 112, 2403-2410 (2005).
18. Davisson, R. L et al. Discovery of a spontaneous genetic mouse model of preeclampsia. Hypertension 39, 337-342 (2002).
19. John, S. VJ. et al. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267, 679-681 (1995).
20. Kuhn, M. et al. The natriuretic peptide/guanylyl cyclase-a system functions as a stress-responsive regulator of angiogenesis in mice. J. Clin. Invest 119, 2019-2030 (2009).
21. Tokudome, T. et al. Impaired recovery of blood flow after hind-limb ischemia in mice lackingguanylylcyclase-A, a receptorforatrial and brain natriuretic peptides. Arterioscler. Thromb. Vase. Biol. 29, 1516-1521 (2009).
22. Dong, N. et al. Plasma soluble corin in patients with heart failure. Circ. Heart Fail. 3, 207-211 (2010).
23. Jiang, J. et al. Ectodomain shedding and autocleavage of the cardiac membrane protease corin. J. Biol. Chem. 286, 10066-10072 (2011).
24. Pan, J. et al. Genomic structures of the human and murine corin genes and functional GATA elements in their promoters. J. Biol. Chem. 277, 38390-38398 (2002).
25. Knappe, S., Wu, F., Madlansacay, M. R. & Wu, Q. Identification of domain structures n the propeptide of corin essential for the processing of proatrial natriuretic peptide. J. Biol. Chem. 279, 34464-34471 (2004).
26. Wang, W. et al. Corin variant associated with hypertension and cardiac hypertrophy exhibits impaired zymogen activation and natriuretic peptide processing activity. Circ. Res. 103, 502-508 (2008).
27. Irons, D. W., Baylis, P. H., Butler, T. J. & Davison, J. M. Atrial natriuretic peptide in preeclampsia: metabolic clearance, sodium excretion and renal hemodynamics. Am. J. Physiol. 273, F483-F487 (1997).
28. Tihtonen, K. M., Koobi, T., Vuolteenaho, O., Huhtala, H. S. & Uotila, J. T. Natriuretic peptides and hemodynamics in preeclampsia. Am. J. Obstet Gynecol. 196, 328. el-328. e7 (2007).
29. Chen, S. et al. Protease corin expression and activity infailing hearts. Am. J. Physiol. Heart Circ. Physiol. 299, H1687-H1692 (2010).
30. Liao, X., Wang, W., Chen, S. & Wu, Q. Role of glycosylation in corin zymogen activation. J. Biol. Chem. 282, 27728-27735 (2007).
31. Dong, N. et al. Effects of anticoagulants on human plasma soluble corin levels measured by ELISA. Clin. Chim. Acta 411, 1998-2003 (2010).
32. Wu, F., Yan, W., Pan, J., Morser, J. & Wu, Q. Processing of pro-atrial natriuretic peptide by corin in cardiac myocytes. J. Biol. Chem. 277, 16900-16905 (2002).
33. Qi, X., Jiang, J., Zhu, M. & Wu, Q. Human corin isoforms with different cytoplasmic tails that alter cell surface targeting. J. Biol. Chem. 286, 20963-20969 (2011).